PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
115 hedge funds and large institutions have $206M invested in Aratana Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
115
Holding in Top 10
3
Calls
$12K
Puts
–
Top Buyers
| 1 | +$2.12M | |
| 2 | +$1.88M | |
| 3 | +$1.47M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.44M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.34M |
Top Sellers
| 1 | -$3.54M | |
| 2 | -$2.78M | |
| 3 | -$1.69M | |
| 4 |
Goldman Sachs
New York
|
-$1.56M |
| 5 |
Renaissance Technologies
New York
|
-$1.18M |